Institute of Immunology, Hannover Medical School, Hannover, Germany.
Eur J Immunol. 2011 Mar;41(3):611-23. doi: 10.1002/eji.201040877. Epub 2011 Feb 10.
Deficiency of transplant recipients for the chemokine receptor CCR7 was originally described to slightly increase the survival time of vascularized solid organ grafts, probably due to a reduced priming of alloreactive T cells. Using a model of allotolerance induction by donor-specific splenocyte transfusion (DST) in combination with anti-CD40L mAb-mediated costimulation blockade (CSB), we show here a striking failure of CCR7-deficient (CCR7(-/-) ) recipients to tolerate cardiac allografts. Furthermore, in addition to the recently described lack of Treg, CCR7(-/-) mice were found to harbor significantly reduced numbers of plasmacytoid dendritic cells (pDCs) within peripheral as well as mesenteric lymph nodes (LNs), but not the bone marrow or spleen. pDCs had previously been suggested to function as tolerogenic APC during allograft transplantation, and a single transfer of syngeneic WT pDCs, but not conventional DCs, was indeed sufficient to rescue graft survival in DST+CSB-treated CCR7(-/-) recipients in a dose-dependent manner. We therefore conclude that the nearly complete absence of pDCs within LNs of CCR7(-/-) mice prevents the successful induction of DST+CSB-mediated allotolerance, leading to the observed acute rejection of cardiac allografts under tolerizing conditions.
受体缺乏趋化因子受体 CCR7 最初被描述为略微延长血管化实体器官移植物的存活时间,这可能是由于同种反应性 T 细胞的初始激活减少。我们使用供体特异性脾细胞输注 (DST) 与抗 CD40L mAb 介导的共刺激阻断 (CSB) 联合诱导同种异体耐受的模型,在此显示 CCR7 缺陷(CCR7(-/-))受体明显不能耐受心脏同种异体移植物。此外,除了最近描述的 Treg 缺乏之外,还发现 CCR7(-/-) 小鼠在外周和肠系膜淋巴结 (LNs) 中以及骨髓或脾脏中明显缺乏浆细胞样树突状细胞 (pDC)。pDC 先前被认为在同种异体移植过程中作为耐受原性 APC 发挥作用,并且单次转移同种型 WT pDC 而不是常规 DC 确实足以以剂量依赖的方式挽救 DST+CSB 处理的 CCR7(-/-) 受体中的移植物存活。因此,我们得出结论,CCR7(-/-) 小鼠 LNs 中 pDC 的几乎完全缺失阻止了 DST+CSB 介导的同种异体耐受的成功诱导,导致在耐受条件下观察到心脏同种异体移植物的急性排斥。